The management of strabismus in patients with chronic progressive external ophthalmoplegia
- PMID: 20521878
- DOI: 10.3109/09273971003758388
The management of strabismus in patients with chronic progressive external ophthalmoplegia
Abstract
Aims: To describe the clinical profiles and results of surgical and non-surgical interventions in a large cohort of patients with strabismus associated with chronic progressive external ophthalmoplegia (CPEO).
Methods: A retrospective case note review was conducted of all patients with a clinical diagnosis of CPEO referred to our institution's strabismus department in the United Kingdom between 1990 and 2008.
Results: The total number of patients in this series was 28 (12 male, 16 female). The main presenting symptoms were diplopia (14) or cosmetically objectionable strabismus (11). Three had symptoms unrelated to strabismus and were excluded from further analysis. The most common strabismus findings were large angle exotropias (mean 47 prism diopters), half of which had associated vertical deviations. Strabismus management consisted of prisms (3), occlusion (3), botulinum toxin (7), and surgery (8). Two patients were offered surgery but were deemed unfit for general anesthesia, and a further 2 declined surgery or defaulted follow-up. Three had no active treatment for strabismus. The most effective procedure for exotropia was maximal, bilateral lateral rectus recessions (8 mm or 17 mm from the limbus) with medial rectus resections (7 mm) using adjustable sutures. Patients who had less than maximal horizontal muscle surgery were inevitably undercorrected, even in the early postoperative period. Long-term stability of measurements was rarely achieved, with either progressive increase in the angle of exotropia, or with new onset vertical deviations.
Conclusions: In selected patients with CPEO and exotropia, maximal bilateral surgery significantly improves ocular alignment and may relieve symptoms of diplopia, but due to the progressive nature of the disease, strabismus often recurs. Toxin can be invaluable in maintaining a satisfactory ocular alignment in patients with residual or progressive exotropias, who have undergone maximal horizontal rectus muscle surgery or multiple previous strabismus procedures.
Similar articles
-
Strabismus surgery for diplopia in chronic progressive external ophthalmoplegia.Int Ophthalmol. 2019 Jan;39(1):213-217. doi: 10.1007/s10792-017-0781-2. Epub 2018 Mar 26. Int Ophthalmol. 2019. PMID: 29582258
-
Two horizontal rectus eye muscle surgery combined with botulinum toxin for the treatment of very large angle esotropia. A pilot study.Binocul Vis Strabismus Q. 2005;20(1):15-20. Binocul Vis Strabismus Q. 2005. PMID: 15828866
-
The use of titanium T-plate as platform for globe alignment in severe paralytic and restrictive strabismus.Am J Ophthalmol. 2010 Sep;150(3):404-411.e1. doi: 10.1016/j.ajo.2010.03.029. Epub 2010 Jun 9. Am J Ophthalmol. 2010. PMID: 20542486
-
One muscle strabismus surgery.Curr Opin Ophthalmol. 2010 Sep;21(5):335-40. doi: 10.1097/ICU.0b013e32833bd953. Curr Opin Ophthalmol. 2010. PMID: 20531188 Review.
-
Diplopia and strabismus following ocular surgeries.Surv Ophthalmol. 2010 Jul-Aug;55(4):335-58. doi: 10.1016/j.survophthal.2009.08.004. Epub 2010 May 8. Surv Ophthalmol. 2010. PMID: 20452637 Review.
Cited by
-
Progressive External Ophthalmoplegia.Curr Neurol Neurosci Rep. 2016 Jun;16(6):53. doi: 10.1007/s11910-016-0652-7. Curr Neurol Neurosci Rep. 2016. PMID: 27072953 Review.
-
Neuro-ophthalmic manifestations of mitochondrial disorders and their management.Taiwan J Ophthalmol. 2020 Dec 4;11(1):39-52. doi: 10.4103/tjo.tjo_68_20. eCollection 2021 Jan-Mar. Taiwan J Ophthalmol. 2020. PMID: 33767954 Free PMC article. Review.
-
Mitochondrial disease heterogeneity: a prognostic challenge.Acta Myol. 2014 Oct;33(2):86-93. Acta Myol. 2014. PMID: 25709378 Free PMC article.
-
Strabismus surgery for diplopia in chronic progressive external ophthalmoplegia.Int Ophthalmol. 2019 Jan;39(1):213-217. doi: 10.1007/s10792-017-0781-2. Epub 2018 Mar 26. Int Ophthalmol. 2019. PMID: 29582258
-
Mitochondria and the eye-manifestations of mitochondrial diseases and their management.Eye (Lond). 2023 Aug;37(12):2416-2425. doi: 10.1038/s41433-023-02523-x. Epub 2023 Apr 25. Eye (Lond). 2023. PMID: 37185957 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources